ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2021 American Transplant Congress

    Endothelial-to-Myofibroblast Transition (en-mt) and Low Expression of Capillary Vegf Enhance the Development of Interstitial Fibrosis and Glomerulosclerosis Induced by Microvascular Destruction in Antibody-Mediated Rejection (abmr) Patients

    B. Ozdemir1, E. Akcay1, A. Ok Atilgan1, M. Haberal2

    1Department of Pathology, Baskent University, Ankara, Turkey, 2Division of Transplantation, Department of General Surgery, Baskent University, Ankara, Turkey

    *Purpose: Interstitial fibrosis (IF) and glomerulosclerosis (GS) are the most important cause of graft loss. Although the rate of microvascular destruction (MVD) is similar in…
  • 2021 American Transplant Congress

    Lymphotoxin Beta Receptor Regulates Treg Migration and Suppression by Modulating Draining Lymphatic Structure

    V. Saxena1, W. Piao1, L. Li1, M. W. Shirkey1, J. Iyyathurai1, R. Lakhan1, R. Abdi2, J. Bromberg1

    1U Maryland, Baltimore, MD, 2Harvard U, Boston, MA

    *Purpose: Regulatory T cells (Treg) must migrate from tissues via lymphatic vessels (LV) to the draining lymph node (dLN) to induce tolerance. During migration, Treg…
  • 2021 American Transplant Congress

    DSA Causes Mild Molecular ABMR-like Changes in Many Biopsies Not Diagnosed as Rejection

    P. F. Halloran1, K. S. Madill-Thomsen1, &. the INTERCOMEX Study Group2

    1Alberta Transplant Applied Genomics Centre, Edmonton, AB, Canada, 2., ., AB, Canada

    *Purpose: In the multicenter study INTERCOMEX, we developed a microarray-based system (MMDx) for diagnosing antibody-mediated and T cell-mediated rejection (ABMR, TCMR) in kidney transplant biopsies…
  • 2021 American Transplant Congress

    A Meta-Analysis of Endoscopic Stents in the Treatment of Anastomotic Biliary Strictures After Liver Transplantation

    F. Zhou1, M. Mieth1, C. Rupp2, A. Mehrabi1, A. Nickkholgh1

    1Department of General, Abdominal and Transplant Surgery, University of Heidelberg, Heidelberg, Germany, 2Department of Internal Medicine, University of Heidelberg, Heidelberg, Germany

    *Purpose: Biliary strictures (BS) are common after orthotopic liver transplantation (OLT). The treatment of choice is endoscopic retrograde cholangiopancreatography (ERCP). Multiple plastic stents (MPS) have…
  • 2021 American Transplant Congress

    Beneficial Effects of Argon Inhalation on Reducing Lung Ischemia-reperfusion Injury in Miniature Swine

    H. Sahara

    Div. Organ Replacement and Xeno Tx, Center for Advanced Biomedical Science and Swine Research, Kagoshima University, Kagoshima, Japan

    *Purpose: Noble gases, such as xenon and argon (Ar), are chemically inert but have shown to have cytoprotective effect. In contrast to xenon, Ar is…
  • 2021 American Transplant Congress

    Long Term Outcomes of Kidney Donors with Fibromuscular Dysplasia

    H. N. Adrogue1, A. Evans1, S. A. Hebert1, H. E. Adrogue1, D. T. Nguyen2, D. Murad1, E. A. Graviss2

    1Medicine, Houston Methodist Hospital, Houston, TX, 2Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, TX

    *Purpose: Fibromuscular dysplasia (FMD) is not an infrequent finding during kidney donor evaluation. Current guidelines do not provide any recommendations regarding the use of kidneys…
  • 2021 American Transplant Congress

    Economic Impact of a Pharmacist-Led Medication Safety Intervention: Report from the Transafe Rx Randomized Controlled Trial

    D. Taber, J. Fleming, Z. Su, P. Mauldin, M. Gebregziabher

    Med Univ of South Carolina, Charleston, SC

    *Purpose: We have previously demonstrated the efficacy of a pharmacist-led, mHealth intervention on reducing medication errors and adverse events leading to reduce hospitalizations in kidney…
  • 2021 American Transplant Congress

    Complement Blockade Improves Renal Xenograft Survival in Primates in the Absence of Transgenic Complement Regulatory Proteins

    D. A. Faber1, B. Lovasik1, A. Matar1, C. Breeden1, A. B. Farris2, M. Tector3, A. Tector3, A. Adams4

    1Surgery, Emory University School of Medicine, Atlanta, GA, 2Pathology, Emory University School of Medicine, Atlanta, GA, 3Surgery, University of Miami, Miami, FL, 4Surgery, University of Minnesota, Minneapolis, MN

    *Purpose: Complement activation is a major contributor to xenograft rejection. To minimize xenograft injury, complement suppression via insertion of human complement-regulatory transgenes into the donor…
  • 2021 American Transplant Congress

    Belatacept for Kidney Transplantation in the Age of Covid19, is it Safe?

    J. Pagan1, S. Anjan2, Y. Natori3, A. Fernandez3, R. Zamora-Gonzalez2, A. Mattiazzi1, L. Mendez1, G. Guerra1

    1Nephrology, University of Miami, Miami, FL, 2Infectious Diseases, University of Miami, Miami, FL, 3Infectious Disease, University of Miami, Miami, FL

    *Purpose: The COVID19 pandemic has affected kidney transplant recipients (KTR) with a wide spectrum of clinical severity. Up to this point, we have solely seen…
  • 2021 American Transplant Congress

    Frailty and Short-Term Outcomes in Kidney Transplant

    S. Van Arsdale1, K. Torbert1, R. Harland2, A. Turner2, B. Tanriover3, V. Ariyamuthu3

    1Banner University Medical Center, Tucson, AZ, 2Surgery, Banner University Medical Center, Tucson, AZ, 3Internal Medicine, Banner University Medical Center, Tucson, AZ

    *Purpose: Studies suggest worse outcomes for frail solid organ transplant recipients. We analyzed post transplant outcomes in relation to frailty.*Methods: We conducted a retrospective study…
  • « Previous Page
  • 1
  • …
  • 88
  • 89
  • 90
  • 91
  • 92
  • …
  • 139
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences